DOD Biotech PCL Stock

DOD Biotech PCL EBIT

The EBIT of DOD Biotech PCL (DOD.BK) as of Aug 10, 2026 is 27.09 M THB. In the previous year, EBIT was 43.49 M THB — a change of -37.72% (lower).

EBIT

27.09 MTHB

YoY

-37.72%

Last updated:

In 2026, DOD Biotech PCL's EBIT was 27.09 M THB, a -37.72% increase from the 43.49 M THB EBIT recorded in the previous year.

The DOD Biotech PCL EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M THB)
Date
EBIT (M THB)
Jan 1, 2018
311.36 base
Jan 1, 2019
87.79 base
Jan 1, 2020
330.81 base
Jan 1, 2021
271.52 base
Jan 1, 2022
-417.13 base
Jan 1, 2023
56.89 base
Jan 1, 2024
43.49 base
Jan 1, 2025
27.09 base
YEAREBIT (M THB)
2025 27.09
2024 43.49
2023 56.89
2022 -417.13
2021 271.52
2020 330.81
2019 87.79
2018 311.36
2017 138.09
2016 131.77
2015 47.27
2014 -0.50
2013 -0.50
Access this data via the Eulerpool API

DOD Biotech PCL Revenue

DOD Biotech PCL Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
666.36 M THB
311.36 M THB
305.26 M THB
Jan 1, 2019
789.92 M THB
87.79 M THB
86.71 M THB
Jan 1, 2020
1.61 B THB
330.81 M THB
141.25 M THB
Jan 1, 2021
1.02 B THB
271.52 M THB
233.10 M THB
Jan 1, 2022
537.16 M THB
-417.13 M THB
-345.12 M THB
Jan 1, 2023
678.15 M THB
56.89 M THB
7.19 M THB
Jan 1, 2024
645.38 M THB
43.49 M THB
-159.33 M THB
Jan 1, 2025
608.98 M THB
27.09 M THB
59.59 M THB

DOD Biotech PCL Margins

DOD Biotech PCL stock margins

The DOD Biotech PCL margin analysis displays the gross margin, EBIT margin, as well as the profit margin of DOD Biotech PCL. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for DOD Biotech PCL.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
61.51 %
46.72 %
45.81 %
Jan 1, 2019
51.89 %
11.11 %
10.98 %
Jan 1, 2020
46.82 %
20.53 %
8.77 %
Jan 1, 2021
42.81 %
26.74 %
22.96 %
Jan 1, 2022
26.16 %
-77.66 %
-64.25 %
Jan 1, 2023
40.08 %
8.39 %
1.06 %
Jan 1, 2024
32.04 %
6.74 %
-24.69 %
Jan 1, 2025
34.49 %
4.45 %
9.78 %

DOD Biotech PCL Stock analysis

What does DOD Biotech PCL do? DOD Biotech PCL is a Thai biotechnology company specializing in the production of pharmaceuticals, diagnostics, and research products. Established in 2004, the company has become one of the most reputable biotechnology companies in Thailand. Its business model is based on the development and manufacturing of products used in medicine, veterinary medicine, and research. DOD Biotech PLC focuses on continually evolving and adapting its products to meet customer needs. Its main areas of focus are the production of pharmaceuticals, particularly anti-cancer drugs, diabetes medications, cardiovascular medications, and infection treatments. Additionally, the company manufactures diagnostics for disease early detection and precise diagnosis. It also offers a variety of products for research purposes. DOD Biotech PCL has partnerships with several companies in other countries, particularly in Asia and Europe. Its largest partner is the Indian company Sun Pharma, with which it has had a successful collaboration for many years. The company is known for its high-quality standards and is certified to ISO 9001:2015 and follows the Good Manufacturing Practices (GMP) required by the Thai FDA. DOD Biotech PCL has received international recognition, including the Frost & Sullivan Thailand Excellence Award and being recognized as a top 30 company in Thailand in 2020. Over the years, the company has built a loyal customer base that appreciates its high-quality products and excellent customer service. It has a strong online presence to better reach and serve its customers. In summary, DOD Biotech PCL is a leading biotechnology company in Thailand with a wide range of pharmaceuticals, diagnostics, and research products. It has earned an excellent reputation for its high-quality standards and top-notch customer service. With its strong online presence and partnerships with other companies in Asia and Europe, DOD Biotech PCL will undoubtedly remain an important player in the global healthcare market in the future. DOD Biotech PCL is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing DOD Biotech PCL's EBIT

DOD Biotech PCL's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of DOD Biotech PCL's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

DOD Biotech PCL's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in DOD Biotech PCL’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about DOD Biotech PCL stock

EBIT of DOD Biotech PCL is 27.09 M THB in 2026.

EBIT of DOD Biotech PCL changed from 43.49 M THB to 27.09 M THB, representing a -37.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT DOD Biotech PCL since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's DOD Biotech PCL historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — DOD Biotech PCL

All Key Metrics — DOD Biotech PCL